Here, we provide a proof of concept and an up-to-date literature review on the effects of ACVR2 counteraction in preclinical cancer- and chemotherapy-induced cachexia models with a special emphasis on the multi-tissue and multi-systemic effects possibly contributing to improved survival. Here, ACVR2A is linked to cancer.